Involvement of cyclooxygenase-derived prostaglandin e2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide

Journal of Physiology and Pharmacology

Volumn 52, Issue 1, 2001, Pages 107-126

  Jaworek, J ^a   Bonior, J ^a   Maszewska, R T ^a   Jachimczak, B ^a   Kot, M ^a   Bielanski W ^a   Pawlik, W W ^a   Sendur, R ^a   Stachura, J ^a   Konturek, P C ^b   Konturek, S J ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Caerulein induced pancreatitis; Cyclooxygenase; Indomethacin; Lipopolysaccharide; Nitric oxide; NS 389; Prostaglandin; Resveratrol; Rofexocib

Indexed keywords

AMYLASE ISOENZYME; ARGININE; BACTERIUM LIPOPOLYSACCHARIDE; CERULETIDE; CERULETIDE DIETHYLAMINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN E2; RESVERATROL; ROFECOXIB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ESCHERICHIA COLI; LASER DOPPLER FLOWMETRY; MALE; NONHUMAN; PANCREAS BLOOD FLOW; PANCREATITIS; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACUTE DISEASE; AMYLASES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CAERULEIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; ENZYME INHIBITORS; INDOMETHACIN; ISOENZYMES; LACTONES; LIPOPOLYSACCHARIDES; MALE; MEMBRANE PROTEINS; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROARGININE; NITROBENZENES; ORGAN SIZE; PANCREAS; PANCREATITIS; PENICILLAMINE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, WISTAR; S-NITROSO-N-ACETYLPENICILLAMINE; STILBENES; SULFONAMIDES; SULFONES;

EID: 0035080505     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Structure-bioactivity relationship of bacterial endotoxins
2. Medical management of acute pancreatitis and complications
3. Enhancement of lipopolysaccharide-induced neutrophil oxygen radical production by tumor necrosis factor
4. Lipopolysaccharide-induced NK-kappaB activation and cytokine release in human alveolar macrophages id PKC-independent and TK-and Pc-PLC-dependent
5. Endotoxemia and serum necrosis factor as prognostic markers in severe acute pancreatitis
6. The effect of chronic intraperitoneal infusion of bacterial endotoxin on exocrine pancreas function in rats
7. Role of platelet activating factor in acute pancreatitis induced by lipopolysaccharide pretreatment
8. Protective role of endogenous nitric oxide (NO) in lipopolysaccharide-induced pancreatic damage. (A new experimental model of acute pancreatitis)
9. DEUSLipopolysaccharide induces superoxide dismutase in the rat pancreas: Role in caerulein pancreatitis
10. Protective action of lipopolysaccharides (LPS) in rat caerulein-induced pancreatitis. Role of nitric oxide
11. Nitric oxide in gastrointestinal physiology and pathology
12. Cytokine-mediated induction of cyclooxygenase-2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide
13. Bacterial lipopolysaccharide protects gastric mucosa against acute injury in rats by activation of genes for cyclooxygenases and endogenous prostaglandins
14. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
15. Nonsteroid drug selectivities for cyclooxygenase-1 rather than cyclooxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis
16. Prostaglandin endoperoxidase synthase: Why two isoforms?
17. Nitric oxide activated cyclooxygenase enzymes
18. Prostanoid generation in early stages of acute pancreatitis a role for nitric oxide
19. Prevention of prostaglandins of caerulein-induced pancreatitis in rats
20. Prostaglandin E1 protects dog pancreas from ischemia-reperfusion injury
21. Protective effects of prostaglandin E1 on acute lung injury of caerulein-induced acute pancreatitis in rats
22. Effect of prostaglandin E on the redistribution of lysosomal enzymes in caerulein-induced pancreatitis
23. Effects of prostaglandins of E, F, and I series, leukotriene C4 and platelet activating factor (PAF) on amylase release from isolated rat pancreatic acini
24. Exacerbation of acute pancreatitis in the presence of chronic liver injury in rats, with special reference to therapeutic efficacy of prostaglandin E1
25. Dual inhibition of nitric oxide and prostaglandin production contributes to the anti-inflammatory properties of nitric oxide synthase inhibitors
26. Nitric oxide in pancreatic secretion and hormone-induced pancreatitis in rats
27. The nucleotide sequence of the rat cytoplasmic beta-actin gene
28. Expression of a mitogen responsive gene encoding prostaglandin synthase is regulated by mRNA splicing
29. Cloning and expression of rat prostaglandin endoperoxide synthase(cyclooxygenase)-2 DNA
30. Selective inhibition of inducible cyclooxygenase-2 in vivo is anti-inflammatory and ulcerogenic
31. Induction of cyclooxygenase 1 and 2 in the rat stomach during endotoxemia: Role in resistance to damage
32. Concordant induction of prostaglandin E2 synthesis with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over tromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rat peritoneal macrophages
33. Aspirin causes rapid up-regulation of cyclooxygenase-2 expression in the stomach of rats
34. Biphasic effect of prostaglandin E1 on the severity of acute pancreatitis induced by a closed duodenal loop in rats
35. Rapid nitric oxide and prostaglandin-dependent release of calcitonin gene-related peptide (CGRP) triggered by endotoxin in rat mesenteric arterial bed